stella
beta
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Stella
Recruiting
Back to Leukemia, Myeloid, Acute trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(5 sites)
United States
UCLA Department of Medicine, Los Angeles, California
Moffitt Cancer Center, Tampa, Florida
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey
Oregon Health and Science University, Portland, Oregon
Vanderbilt University, Ingram Cancer Center, Nashville, Tennessee
View full record on ClinicalTrials.gov